Insider Transactions in Q2 2022 at Immuneering Corp (IMRX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 25
2022
|
Brett Matthew Hall CHIEF SCIENTIFIC OFFICER |
BUY
Open market or private purchase
|
Direct |
2,551
+0.76%
|
$7,653
$3.92 P/Share
|
|
May 17
2022
|
Michael Bookman CHIEF LEGAL OFFICER, SECRETARY |
BUY
Open market or private purchase
|
Direct |
1,000
+29.39%
|
$4,000
$4.88 P/Share
|
|
May 16
2022
|
Laurie Keating Director |
BUY
Open market or private purchase
|
Direct |
7,000
+33.33%
|
$35,000
$5.0 P/Share
|
|
May 12
2022
|
Biren Amin CFO, TREASURER |
BUY
Open market or private purchase
|
Direct |
1,000
+11.24%
|
$4,000
$4.42 P/Share
|
|
Apr 12
2022
|
Benjamin J. Zeskind PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+0.09%
|
$6,000
$3.01 P/Share
|